FGF R4

FGF R4 분자 정보

영어 이름Fibroblast growth factor receptor 4시판 약물 수3
임상 약물 수19표적 별명CD334 Antigen,EC 2.7.10.1,FGFR-4,Receptor, Fibroblast Growth Factor, Type 4,EC 2.7.10,JTK2,Tyrosine Kinase Related To Fibroblast Growth Factor Receptor,Hydroxyaryl-Protein Kinase,Tyrosylprotein Kinase,EC:2.7.10.1,Fibroblast growth factor receptor 4,CD334,FGFR4,TKF
최고 연구 개발 단계Approved
영어 이름Fibroblast growth factor receptor 4
표적 별명CD334 Antigen,EC 2.7.10.1,FGFR-4,Receptor, Fibroblast Growth Factor, Type 4,EC 2.7.10,JTK2,Tyrosine Kinase Related To Fibroblast Growth Factor Receptor,Hydroxyaryl-Protein Kinase,Tyrosylprotein Kinase,EC:2.7.10.1,Fibroblast growth factor receptor 4,CD334,FGFR4,TKF
시판 약물 수3
임상 약물 수19
최고 연구 개발 단계Approved

FGF R4 제품 목록

  • 속성

    Protein (2)

  • 제품 라이브러리

    온라인 (2)

  • Human (2)

  • 태그

    His Tag (1)Fc Tag (1)

  • 마커

    Unconjugated (2)

제품 번호발현 시스템제품 설명단백질 구조순도특성
Human
HEK293
Human FGF R4 / CD334 Protein, His Tag, low endotoxin
Human
HEK293
Human FGF R4 / CD334 Protein, Fc Tag (MALS & SPR verified)
총 수량2
  • 1

FGF R4분자 배경

Fibroblast growth factor receptor 4(FGFR4) is also known as CD334, JTK2, hydroxyaryl-protein kinase, TKF, protein-tyrosine kinase . The FGFR4 gene provides instructions for making a protein called fibroblast growth factor receptor 4. This protein is part of a family of fibroblast growth factor receptors that share similar structures and functions. These receptor proteins play a role in important processes such as cell division, regulating cell growth and maturation, formation of blood vessels, wound healing, and embryo development.The FGFR4 protein interacts with specific growth factors to conduct signals from the environment outside the cell to the nucleus. The nucleus responds to these signals by switching on or off appropriate genes that help the cell adjust to changes in the environment. In response, the cell might divide, move, or mature to take on specialized functions. Although specific functions of FGFR4 remain unclear, studies indicate that the gene is involved in muscle development and the maturation of bone cells in the skull. The FGFR4 gene may also play a role in the development and maintenance of specialized cells (called foveal cones) in the light-sensitive layer (the retina) at the back of the eye.

FGF R4분자 별명

FGFR4,CD334,JTK2,MGC20292,TKF

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
SC-0011SC-0011Phase 3 ClinicalShijiazhuang Zhikang Hongren New Drug Development Co LtdCarcinoma, Non-Small-Cell Lung; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Solid tumours; Stomach Neoplasms
상세
AUR-109ODM-203; AUR-109Phase 2 ClinicalOrion CorpBreast Neoplasms; Carcinoma, Renal Cell; Colorectal Neoplasms; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Ovarian Neoplasms; Pulmonary Fibrosis; Solid tumours; Urinary Bladder Neoplasms
상세
RogaratinibBAY-1163877Phase 2 ClinicalBayer AGBreast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Gastrointestinal Stromal Tumors; Metastatic breast cancer; Neoplasms; Sarcoma; Solid tumours; Urinary Bladder Neoplasms
상세
FisogatinibBLU-554; CS-3008Phase 2 ClinicalBlueprint Medicines CorpCarcinoma, Hepatocellular
상세
BB-102BB-102; BB102Phase 2 ClinicalBroadenbio Co LtdCarcinoma, Hepatocellular; Solid tumours
상세
GunagratinibICP-192Phase 2 ClinicalBeijing Tiancheng Pharmaceutical Technology Co LtdBiliary Tract Neoplasms; Carcinoma, Transitional Cell; Cholangiocarcinoma; Head and Neck Neoplasms; Lung Neoplasms; Solid tumours; Stomach Neoplasms; Urinary Bladder Neoplasms
상세
IrpagratinibABSK-011Phase 2 ClinicalABbisko Therapeutics Co LtdCarcinoma, Hepatocellular; Liver Neoplasms; Solid tumours
상세
BPI-43487BPI-43487Phase 1 ClinicalBetta Pharmaceuticals Co LtdBiliary Tract Neoplasms; Carcinoma, Hepatocellular; Solid tumours
상세
HS-236HS-236Phase 1 ClinicalZhejiang Hisun Pharmaceutical Co LtdSolid tumours
상세
HS-10340HS-10340Phase 1 ClinicalChangzhou Hengbang Pharmaceutical Co Ltd, Jiangsu Hansoh Pharmaceutical Group Co Ltd, Shanghai Hansoh Biomedical Co LtdSolid tumours
상세
ICP-105ICP-105Phase 1 ClinicalBeijing Innocare Pharma Tech Co Ltd, Beijing Tiancheng Pharmaceutical Technology Co Ltd, Nanjing Tianyin Jianhua Pharmaceutical Technology Co LtdLiver Neoplasms; Solid tumours
상세
ZSP-1241ZSP-1241Phase 1 ClinicalGuangdong Zhongsheng Pharmaceutical Co Ltd, Wuxi Apptec Co LtdBiliary Tract Neoplasms; Carcinoma; Carcinoma, Hepatocellular; Cholangiocarcinoma; Colorectal Neoplasms; Esophageal Neoplasms; Liver Neoplasms; Stomach Neoplasms
상세
H3B-6527H3B-6527Phase 1 ClinicalH3 Biomedicine IncCarcinoma, Hepatocellular; Liver Neoplasms
상세
FGFR4-CAR T Cells Therapy(National Cancer Institute)Phase 1 ClinicalNational Cancer InstituteRhabdomyosarcoma
상세
TYRA-430TYRA-430Phase 1 ClinicalTyra Biosciences IncCarcinoma, Hepatocellular; Neoplasms; Solid tumours
상세
SYHX-2005SYHX-2005; SYHX2005Phase 1 ClinicalCspc Ouyi Pharmaceutical Co LtdSolid tumours
상세
JAB-6343Phase 1 ClinicalJacobio Pharmaceuticals Co LtdSolid tumours
상세
SY-4798SY-4798Phase 1 ClinicalShouyao Holding (Beijing) Co LtdBiliary Tract Neoplasms; Carcinoma, Hepatocellular; Solid tumours
상세
ABSK-012ABSK-012; ABSK012Phase 1 ClinicalABbisko Therapeutics Co LtdSolid tumours
상세

시판 약물 정보

영어 이름연구 코드연구 개발 단계회사가장 빠른 브랜드 이름가장 빠른 승인 국가가장 빠른 적응증가장 빠른 승인 회사가장 빠른 승인 날짜적응증임상 시험
Lenvatinib MesilateE-7080; MK-7902; ER-203492-00ApprovedEisai Co LtdKisplyx, Lenvima, Lenvima/Kisplyx, 乐卫玛United StatesThyroid NeoplasmsEisai Inc2015-02-13Adenocarcinoma; Adenocarcinoma of Lung; Adenocarcinoma, Follicular; Biliary Tract Neoplasms; Breast Neoplasms; Carcinoma, Adenoid Cystic; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Cholangiocarcinoma; Endometrial Neoplasms; Esophageal Neoplasms; Gastrointestinal Stromal Tumors; Glioma; Hepatic Insufficiency; Liver Diseases; Liver Neoplasms; Lymphoma; Melanoma; Neoplasm Metastasis; Neoplasms; Neuroendocrine Tumors; Osteosarcoma; Ovarian Neoplasms; Paraganglioma; Pheochromocytoma; Renal Insufficiency; Solid tumours; Stomach Neoplasms; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Uterine Cervical Neoplasms
상세
FutibatinibTAS-120ApprovedOtsuka Pharmaceutical Co Ltd, Taiho Pharmaceutical Co LtdLYTGOBIUnited StatesCholangiocarcinomaTaiho Oncology Inc2022-09-30Biliary Tract Neoplasms; Bone Marrow Neoplasms; Breast Neoplasms; Carcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Central Nervous System Neoplasms; Cholangiocarcinoma; Endometrial Neoplasms; Esophageal Neoplasms; Lymphoma; Metastatic breast cancer; Neoplasm Metastasis; Neoplasms; Sarcoma; Solid tumours; Stomach Neoplasms
상세
Erdafitinib890E37NHMV; G-024; JNJ-493; JNJ-42756493; TAR-210ApprovedAstex Pharmaceuticals IncBalversa, 博珂United StatesCarcinoma, Transitional CellJanssen Biotech Inc2019-04-12Adenocarcinoma; Bile Duct Neoplasms; Bone metastases; Carcinoma; Carcinoma, Hepatocellular; Carcinoma, Neuroendocrine; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Central Nervous System Neoplasms; Ependymoma; Esophageal Neoplasms; Glioma; Hepatic Insufficiency; Hepatoblastoma; Histiocytic Sarcoma; Histiocytosis, Langerhans-Cell; Lymphoma; Lymphoma, Non-Hodgkin; Medulloblastoma; Metastatic breast cancer; Multiple Myeloma; Neoplasms; Neoplasms, Germ Cell and Embryonal; Neuroblastoma; Neuroectodermal Tumors, Primitive, Peripheral; Osteosarcoma; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Rhabdoid Tumor; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Solid tumours; Stomach Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Wilms Tumor; Xanthogranuloma, Juvenile
상세
  • 분자 정보
  • 제품 목록
  • 시판 약물 정보
  • 임상 약물 정보
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호